Back

Optimal rivaroxaban dose in asian patients with atrial fibrillation and normal or mildly impaired renal function

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation and oral anticoagulation 3 Oral Anticoagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Eue-Keun Choi

Seoul National University Hospital, Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
Doctor A. Nissen Bonde (Roskilde, DK)
Abstract Slides
Presentation thumbnail
Professor T. Weiss (St. Polten, AT)
Abstract
Presentation thumbnail
Professor E. Klok (Leiden, NL)
Abstract
Presentation thumbnail
Doctor X. Li (Princeton, US)
Abstract Slides
Presentation thumbnail
Professor Y. Guo (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation and oral anticoagulation 3

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry- is dosing according to renal function appropriate?
27 August 2021
thumbnail
Congress Presentation
Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race
27 August 2021
thumbnail
Congress Presentation
Impact of renal impairment and other high bleeding risk factors on clinical outcomes among Asian patients with atrial fibrillation on edoxaban: a post hoc analysis of the ETNA-AF program
12 April 2026
thumbnail
Congress Presentation
The prescription trend of standard medication depending on kidney function in hospitalized heart failure with reduced ejection fraction patients - Korean multicenter registry data
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources